ALHC
Alignment Healthcare, Inc. NASDAQ Listed Mar 26, 2021$21.86
After hrs
$21.86
+0.00%
Mkt Cap $4.3B
52w Low $11.64
84.0% of range
52w High $23.81
50d MA $18.68
200d MA $18.71
P/E (TTM)
-5908.1x
EV/EBITDA
90.0x
P/B
24.1x
Debt/Equity
1.9x
ROE
-0.4%
P/FCF
38.3x
RSI (14)
76.70
ATR (14)
$1.28
Beta
1.20
50d MA
$18.68
200d MA
$18.71
Avg Volume
7.1M
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada. It also coordinates and provides covered health care services, including professional, institutional, and ancillary services to members enrolled in certain benefit plans of unaffiliated Medicare Advantage Health Maintenance Organizations. The company was founded in 2013 and is based in Orange, California.
1100 West Town and Country Road · Orange, CA 92868 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | AMC | 0.01 | 0.05 | +400.0% | 22.54 | -6.3% | -10.1% | -4.9% | -5.0% | -0.9% | +0.6% | — |
| Feb 26, 2026 | AMC | -0.15 | -0.05 | +66.7% | 20.42 | -7.7% | -5.9% | +2.2% | -6.1% | +2.3% | -1.6% | — |
| Oct 30, 2025 | AMC | -0.01 | 0.02 | +300.0% | 17.12 | +8.2% | -1.5% | -0.1% | +1.5% | -0.2% | -3.3% | — |
| Jul 30, 2025 | AMC | -0.07 | 0.07 | +200.0% | 13.00 | +15.4% | +6.0% | -5.9% | +5.3% | -1.8% | +2.2% | — |
| May 1, 2025 | AMC | -0.12 | -0.05 | +58.3% | 16.77 | +1.7% | -7.4% | -0.3% | +1.6% | -1.3% | -0.6% | — |
| Feb 27, 2025 | AMC | -0.18 | -0.16 | +11.1% | 13.47 | +11.8% | +16.5% | -1.1% | +1.5% | +0.4% | -3.5% | — |
| Oct 29, 2024 | AMC | -0.14 | -0.14 | +0.0% | 11.71 | +0.0% | +0.2% | +5.7% | +4.4% | +2.6% | -0.1% | — |
| Aug 1, 2024 | AMC | -0.14 | -0.13 | +7.1% | 8.62 | +3.8% | +3.7% | -1.2% | +3.9% | -4.6% | -3.8% | — |
| May 2, 2024 | AMC | -0.24 | -0.25 | -4.2% | 5.26 | +8.7% | +26.0% | +2.3% | +1.3% | -1.3% | +1.9% | — |
| Feb 27, 2024 | AMC | -0.22 | -0.25 | -13.6% | 6.92 | -5.3% | -18.2% | +6.0% | -6.0% | -4.3% | +1.3% | — |
| Nov 2, 2023 | AMC | -0.19 | -0.19 | +0.0% | 6.35 | +6.1% | -5.2% | -3.0% | +5.8% | +1.1% | -5.4% | — |
| Aug 3, 2023 | AMC | -0.21 | -0.15 | +28.6% | 5.78 | +14.5% | +11.6% | +0.9% | +1.8% | +0.2% | -1.7% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1 | UBS | Maintains | Neutral → Neutral | — | $22.54 | $21.12 | -6.3% | -10.1% | -4.9% | -5.0% | -0.9% | +0.6% |
| May 1 | Barclays | Maintains | Equal Weight → Equal Weight | — | $22.54 | $21.12 | -6.3% | -10.1% | -4.9% | -5.0% | -0.9% | +0.6% |
| Feb 5 | JP Morgan | Maintains | Overweight → Overweight | — | $21.33 | $21.53 | +0.9% | -0.8% | +2.8% | -4.6% | -0.6% | -1.2% |
| Jan 16 | TD Cowen | Maintains | Buy → Buy | — | $22.50 | $22.48 | -0.1% | +0.0% | +1.1% | +2.5% | +1.3% | +0.8% |
| Jan 14 | UBS | Maintains | Neutral → Neutral | — | $20.92 | $20.99 | +0.3% | +4.0% | +3.4% | +0.0% | +1.1% | +2.5% |
| Jan 6 | Piper Sandler | Maintains | Overweight → Overweight | — | $21.00 | $21.45 | +2.1% | +1.4% | -1.7% | +0.1% | -0.8% | +2.4% |
| Dec 17 | JP Morgan | Maintains | Overweight → Overweight | — | $20.03 | $20.07 | +0.2% | +2.6% | -0.7% | +0.0% | -1.1% | -3.3% |
| Nov 24 | JP Morgan | Upgrade | Neutral → Overweight | — | $16.70 | $17.38 | +4.1% | +5.5% | +8.6% | +0.4% | -0.1% | -0.7% |
| Nov 5 | JP Morgan | Maintains | Neutral → Neutral | — | $17.09 | $16.96 | -0.8% | -0.2% | -3.3% | -1.0% | +0.3% | +0.6% |
| Nov 3 | Barclays | Maintains | Equal Weight → Equal Weight | — | $16.86 | $17.00 | +0.8% | -0.1% | +1.5% | -0.2% | -3.3% | -1.0% |
| Oct 31 | UBS | Maintains | Neutral → Neutral | — | $17.12 | $18.53 | +8.2% | -1.5% | -0.1% | +1.5% | -0.2% | -3.3% |
| Aug 25 | KeyBanc Capital Markets | Upgrade | Sector Weight → Overweight | — | $15.84 | $16.23 | +2.5% | -1.6% | +0.6% | +2.9% | +1.1% | +0.2% |
| Jul 31 | Barclays | Upgrade | Underweight → Equal Weight | — | $13.00 | $15.00 | +15.4% | +6.0% | -5.9% | +5.3% | -1.8% | +2.2% |
| May 2 | UBS | Maintains | Neutral → Neutral | — | $16.77 | $17.05 | +1.7% | -7.4% | -0.3% | +1.6% | -1.3% | -0.6% |
| Apr 15 | Baird | Maintains | Outperform → Outperform | — | $19.13 | $19.52 | +2.0% | +1.6% | +0.3% | -6.4% | -4.1% | +3.8% |
| Apr 8 | Stifel | Maintains | Buy → Buy | — | $17.82 | $19.73 | +10.7% | +6.3% | -2.2% | +6.7% | -0.2% | -3.1% |
| Mar 6 | JP Morgan | Maintains | Neutral → Neutral | — | $15.81 | $15.65 | -1.0% | -3.5% | -2.4% | +0.9% | +2.7% | +1.9% |
| Mar 4 | BofA Securities | Maintains | Buy → Buy | — | $15.52 | $15.53 | +0.1% | +1.5% | +0.4% | -3.5% | -2.4% | +0.9% |
| Mar 4 | Piper Sandler | Maintains | Overweight → Overweight | — | $15.52 | $15.53 | +0.1% | +1.5% | +0.4% | -3.5% | -2.4% | +0.9% |
| Feb 28 | Stifel | Maintains | Buy → Buy | — | $13.47 | $15.06 | +11.8% | +16.5% | -1.1% | +1.5% | +0.4% | -3.5% |
| Feb 28 | Barclays | Maintains | Underweight → Underweight | — | $13.47 | $15.06 | +11.8% | +16.5% | -1.1% | +1.5% | +0.4% | -3.5% |
| Feb 24 | Stephens & Co. | Maintains | Overweight → Overweight | — | $13.18 | $13.36 | +1.4% | +3.4% | -1.8% | -1.7% | +2.4% | +16.5% |
| Jan 14 | Stifel | Maintains | Buy → Buy | — | $13.50 | $13.78 | +2.1% | +0.1% | +2.9% | +4.7% | +0.2% | -0.1% |
| Jan 2 | Stephens & Co. | Maintains | Overweight → Overweight | — | $11.25 | $11.32 | +0.6% | +2.8% | +1.2% | -3.2% | +3.6% | +2.0% |
| Dec 3 | Stephens & Co. | Upgrade | Equal Weight → Overweight | — | $12.84 | $13.29 | +3.5% | -2.3% | -0.2% | -2.6% | -6.6% | +0.4% |
| Oct 31 | TD Cowen | Maintains | Buy → Buy | — | $11.73 | $11.70 | -0.3% | +5.7% | +4.4% | +2.6% | -0.1% | +6.6% |
| Oct 30 | Barclays | Maintains | Underweight → Underweight | — | $11.71 | $11.71 | +0.0% | +0.2% | +5.7% | +4.4% | +2.6% | -0.1% |
| Oct 30 | UBS | Maintains | Neutral → Neutral | — | $11.71 | $11.71 | +0.0% | +0.2% | +5.7% | +4.4% | +2.6% | -0.1% |
| Aug 14 | Baird | Maintains | Outperform → Outperform | — | $8.49 | $8.78 | +3.4% | +2.1% | -0.9% | +1.3% | -1.3% | -1.2% |
| Aug 6 | TD Cowen | Maintains | Buy → Buy | — | $8.83 | $9.09 | +2.9% | +3.9% | -4.6% | -3.8% | +2.4% | -4.2% |
| Aug 6 | Piper Sandler | Maintains | Overweight → Overweight | — | $8.83 | $9.09 | +2.9% | +3.9% | -4.6% | -3.8% | +2.4% | -4.2% |
| Aug 5 | Barclays | Maintains | Underweight → Underweight | — | $8.94 | $8.50 | -4.9% | -1.2% | +3.9% | -4.6% | -3.8% | +2.4% |
| Jul 26 | Stifel | Maintains | Buy → Buy | — | $9.36 | $9.80 | +4.7% | -4.6% | -4.1% | +2.3% | -0.2% | -1.4% |
| May 8 | Piper Sandler | Upgrade | Neutral → Overweight | — | $6.87 | $7.27 | +5.8% | -1.3% | +1.9% | -1.2% | +1.3% | +1.2% |
| May 3 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $5.26 | $5.72 | +8.7% | +26.0% | +2.3% | +1.3% | -1.3% | +1.9% |
| Apr 23 | Stifel | Maintains | Buy → Buy | — | $5.01 | $5.00 | -0.2% | +3.4% | +0.0% | -0.4% | +1.0% | -2.5% |
| Mar 6 | Piper Sandler | Downgrade | Overweight → Neutral | — | $5.47 | $5.18 | -5.3% | -1.8% | +0.4% | +0.0% | -1.7% | -4.5% |
| Feb 28 | UBS | Maintains | Neutral → Neutral | — | $6.92 | $6.55 | -5.3% | -18.2% | +6.0% | -6.0% | -4.3% | +1.3% |
| Jan 9 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $9.00 | $8.99 | -0.1% | -1.9% | -3.6% | -2.9% | -5.2% | -6.3% |
| Jan 9 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $9.00 | $8.99 | -0.1% | -1.9% | -3.6% | -2.9% | -5.2% | -6.3% |
| Dec 21 | UBS | Maintains | Neutral → Neutral | — | $8.06 | $8.21 | +1.9% | +8.4% | -1.0% | +0.6% | +0.1% | +0.3% |
| Nov 2 | BofA Securities | Downgrade | Buy → Neutral | — | $6.66 | $6.50 | -2.4% | -4.7% | -5.2% | -3.0% | +5.8% | +1.1% |
| Oct 16 | Raymond James | Upgrade | Outperform → Strong Buy | — | $6.62 | $7.61 | +15.0% | +17.2% | -2.2% | -2.4% | -2.7% | -1.5% |
| Aug 30 | Morgan Stanley | Maintains | Overweight → Overweight | — | $6.01 | $5.98 | -0.5% | +1.2% | -3.9% | -1.5% | +0.7% | -2.1% |
| Jul 14 | Morgan Stanley | Maintains | Overweight → Overweight | — | $5.19 | $5.27 | +1.5% | +3.1% | +1.1% | +1.5% | +2.6% | +3.2% |
| Jul 13 | UBS | Maintains | Neutral → Neutral | — | $5.32 | $5.30 | -0.4% | -2.4% | +3.1% | +1.1% | +1.5% | +2.6% |
| Jul 7 | JP Morgan | Maintains | Neutral → Neutral | — | $5.56 | $5.51 | -0.9% | +1.3% | -1.1% | +3.8% | -8.0% | -2.4% |
| May 1 | Raymond James | Upgrade | Market Perform → Outperform | — | $6.29 | $6.71 | +6.7% | +8.9% | -1.0% | -1.8% | +5.1% | -1.6% |
| Apr 19 | Goldman Sachs | Maintains | Buy → Buy | — | $5.95 | $5.95 | +0.0% | -11.6% | -2.7% | +3.9% | +0.6% | +1.5% |
| Mar 3 | Goldman Sachs | Maintains | Buy → Buy | — | $7.40 | $7.40 | +0.0% | +2.7% | -5.1% | -4.3% | -0.3% | -5.5% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | KONOWIECKI JOSEPH SDir/Off | EVP, Corporate Affairs | Sell | 25,000 | $22.00 | $550K | 1,153,816 | — | — |
| Jun 15, 2026 | Maroney Dawn ChristineOff | President | Sell | 30,000 | $19.55 | $586K | 947,313 | +4.15% | — |
| Jun 12, 2026 | Kim HyongOff | Chief Medical Officer | Sell | 35,951 | $19.86 | $714K | 331,750 | +4.15% | — |
| Jun 11, 2026 | KONOWIECKI JOSEPH SDir/Off | EVP, Corporate Affairs | Sell | 25,000 | $21.00 | $525K | 1,178,816 | +0.15% | — |
| Jun 10, 2026 | KAO JOHN EDir/Off | Chief Executive Officer | Sell | 223,064 | $20.60 | $4.6M | 1,386,766 | +0.15% | — |
| Jun 10, 2026 | KAO JOHN EDir/Off | Chief Executive Officer | Sell | 74,936 | $19.65 | $1.5M | 1,609,830 | +0.15% | — |
| Jun 2, 2026 | Kent Mark D.Off | President - MSO | Buy | 14,848 | $13.31 | $198K | 14,848 | +4.47% | +25.08% |
| May 15, 2026 | Maroney Dawn ChristineOff | President | Sell | 30,000 | $16.09 | $483K | 998,813 | +1.83% | -0.62% |
| May 11, 2026 | KAO JOHN EDir/Off | Chief Executive Officer | Sell | 17,107 | $17.54 | $300K | 1,508,641 | -9.36% | +1.83% |
| May 11, 2026 | KAO JOHN EDir/Off | Chief Executive Officer | Sell | 280,893 | $16.85 | $4.7M | 1,525,748 | -9.36% | +1.83% |
8-K
Alignment Healthcare, Inc. -- 8-K Filing
Alignment Healthcare filed a standard 8-K report, indicating a corporate event requiring SEC disclosure, though the specific triggering event details are not provided in this excerpt.
Jun 9
8-K
Alignment Healthcare, Inc. -- 8-K Filing
Alignment Healthcare (ALHC) exceeded expectations with 33.3% revenue growth to $1.24 billion and 30.9% Medicare Advantage membership growth, raising full-year guidance across all metrics.
Apr 30
8-K
Alignment Healthcare, Inc. -- 8-K Filing
Alignment Healthcare completed a securities offering with legal opinions filed, indicating the company proceeded with a planned equity issuance under SEC registration.
Mar 4
8-K
Alignment Healthcare, Inc. -- 8-K Filing
Alignment Healthcare reported strong fourth quarter and full-year 2025 Medicare Advantage results, with CEO John Kao highlighting successful operational execution in the growing senior health insurance market.
Feb 26
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Fmr Llc | 15,892,064 | $280M | Added | Mar 2026 |
| 2 | Vanguard Portfolio Management Llc | 9,710,071 | $171M | New | Mar 2026 |
| 3 | Vanguard Capital Management Llc | 7,973,663 | $140M | New | Mar 2026 |
| 4 | Invesco Ltd. | 7,000,099 | $123M | Added | Mar 2026 |
| 5 | Hood River Capital Management Llc | 6,054,477 | $107M | Reduced | Mar 2026 |
| 6 | Citadel Advisors Llc | 5,362,666 | $94M | Added | Mar 2026 |
| 7 | Morgan Stanley | 4,725,092 | $93M | Added | Dec 2025 |
| 8 | William Blair Investment Management, Llc | 5,214,614 | $92M | Added | Mar 2026 |
| 9 | Voya Investment Management Llc | 3,672,439 | $73M | Added | Dec 2025 |
| 10 | Millennium Management | 3,838,020 | $68M | Added | Mar 2026 |
| 11 | Capital Research Global Investors | 3,593,576 | $63M | New | Mar 2026 |
| 12 | Bank Of New York Mellon Corp | 3,313,110 | $58M | Added | Mar 2026 |
| 13 | Bank Of America Corp /de/ | 3,215,667 | $57M | Added | Mar 2026 |
| 14 | Renaissance Technologies Llc | 2,903,100 | $51M | Added | Mar 2026 |
| 15 | Capital World Investors | 2,666,058 | $47M | Added | Mar 2026 |
| 16 | Danica Pension, Livsforsikringsaktieselskab | 2,503,577 | $44M | Added | Mar 2026 |
| 17 | Allspring Global Investments Holdings, Llc | 2,458,400 | $44M | Added | Mar 2026 |
| 18 | Point72 Asset Management | 2,439,637 | $43M | Added | Mar 2026 |
| 19 | Next Century Growth Investors Llc | 2,262,076 | $40M | Reduced | Mar 2026 |
| 20 | Northern Trust Corp | 1,583,617 | $28M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$4.33B
Enterprise Value
$4.07B
P/E (TTM)
-5908.11x
Forward P/E
168.80x
PEG Ratio
54.31x
P/B
24.14x
P/S
1.10x
P/FCF
38.26x
EV/EBITDA
90.04x
Shares Out
198.0M
Financials (TTM)
Revenue
$3.95B
Net Income
-$724K
EBITDA
$45.2M
Free Cash Flow
$113.1M
Op Cash Flow
$139.9M
EPS Basic
$-0.00
EPS Diluted
$-0.00
EPS Forward
$0.13
Gross Margin
12.4%
Op Margin
0.4%
Net Margin
-0.0%
Balance Sheet
Total Assets
$1.07B
Total Liab.
$886.5M
Total Equity
$179.3M
Cash
$577.9M
LT Debt
$323.2M
Book Value/Sh
$0.91
Debt/Equity
1.89x
Current Ratio
1.74
Quick Ratio
1.74
Returns & Growth
ROE
-0.4%
ROA
-0.1%
ROIC
2.5%
Rev Growth YoY
+46.1%
EPS Growth YoY
+99.5%
Price Returns
2W
-7.5%
1M
-32.0%
3M
-20.3%
6M
-20.2%
12M
-0.3%
Technicals
52W High
$23.81
52W Low
$11.64
50d MA
$18.68
200d MA
$18.71
RSI (14)
76.70
ATR (14)
$1.28
Beta
1.20
Avg Volume
7.1M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$24.50
High
$30.00
Low
$18.00
Median
$25.00
Data updated apr 24, 2026 5:16pm
· Source: financialmodelingprep.com